Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8605334 | The Journal of Pain | 2018 | 21 Pages |
Abstract
This article evaluates the effect of dose reduction and risk mitigation initiatives, such as those recently recommended by the Centers for Disease Control and Prevention, to reduce risks associated with COT on global pain and interference, depressive symptoms, and perceived pain relief and bothersomeness of side effects.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Manu Thakral, Rod L. Walker, Kathleen Saunders, Susan M. Shortreed, Michael Parchman, Ryan N. Hansen, Evette Ludman, Karen J. Sherman, Sascha Dublin, Michael Von Korff,